Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MACK | BMY | AMGN | GILD | REGN |
| Company | Merrimack Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 14.68 | 48.21 | 264.63 | 66.25 | 913.97 |
| High | 14.73 | 48.67 | 267.64 | 66.72 | 920.73 |
| Low | 14.68 | 48.12 | 260.68 | 66.16 | 891.61 |
| Last | 14.69 | 48.56 | 266.57 | 66.33 | 893.68 |
| Change | +0.01 | +0.26 | +3.82 | +0.17 | -0.31 |
| % Change | +0.07% | +0.54% | +1.45% | +0.26% | -0.03% |
| Volume | 33,500 | 2,945,979 | 948,455 | 2,822,841 | 175,398 |
| 20-Day Average Volume | 121,874 | 10,928,166 | 2,123,125 | 6,060,265 | 420,534 |
| Previous Close | 14.68 | 48.30 | 262.75 | 66.16 | 893.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.72 | 50.84 | 272.45 | 69.88 | 934.96 |
| 20-Day Raw Stochastic | 16.00% | 14.51% | 21.41% | 5.65% | 2.20% |
| 20-Day Relative Strength | 58.83% | 39.35% | 41.46% | 29.02% | 32.98% |
| Weighted Alpha | +23.48 | -29.54 | +6.41 | -24.97 | +11.65 |
| Today's Opinion | 80% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 80% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 88% Buy | 24% Sell | 8% Sell | 72% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.14% since 04/12/24 | +0.68% since 04/12/24 | -0.24% since 04/12/24 | -2.53% since 04/12/24 | -1.37% since 04/12/24 |
| Low | 14.66 on 04/16/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 14.73 on 04/19/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | +0.07% since 03/19/24 | -6.16% since 03/19/24 | -1.87% since 03/19/24 | -9.62% since 03/19/24 | -7.40% since 03/19/24 |
| Low | 14.66 on 04/16/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 14.91 on 03/25/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | +11.36% since 01/19/24 | -2.99% since 01/19/24 | -13.37% since 01/19/24 | -23.99% since 01/19/24 | -4.40% since 01/19/24 |
| Low | 12.94 on 02/08/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 15.89 on 02/13/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +20.39% since 10/19/23 | -13.93% since 10/19/23 | -4.97% since 10/19/23 | -15.41% since 10/19/23 | +10.35% since 10/19/23 |
| Low | 12.00 on 11/07/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 15.89 on 02/13/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 213,330 | 97,892,464 | 140,812,720 | 82,374,304 | 98,126,128 |
| Shares Outstanding, K | 14,532 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -1,180,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -240,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.43 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 03/07/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | 05/30/17 | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 23.98 |